Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano
  • Treatment-resistant psychot...
    Harner, Matthew K.; Lichtenstein, Maya; Farrell, Martilias; Dietterich, Tyler E.; Filmyer, Dawn M.; Bruno, Lisa M.; Biondi, Tamara F.; Crowley, James J.; Lázaro-Muñoz, Gabriel; Stowe, Robert; Shaughnessy, Rita A.; Berg, Jonathan S.; Szatkiewicz, Jin; Sullivan, Patrick F.; Josiassen, Richard C.

    Schizophrenia research, 10/2020, Letnik: 224
    Journal Article

    The 3q29 deletion is a rare copy number variant associated with neurodevelopmental and psychiatric disorders, including a >40-fold increased risk for schizophrenia. Current understanding of the clinical phenotype is derived primarily from published cases of patients in childhood or early adolescence. Symptoms include mild to moderate learning disability, developmental delay, facial dysmorphism, microcephaly, ocular disorders, and gastrointestinal abnormalities. There is, however, a lack of detailed longitudinal case studies describing 3q29 deletion syndrome in adults with psychosis. In this case report, we describe the lifetime clinical portrait of a 57-year-old woman with 3q29 deletion syndrome, treatment-resistant psychotic symptoms, multiple medical comorbidities, and a previously unreported co-occurrence of early-onset dementia.